J&J HIV shot fails, adding another blow to decades-long effort to curb epidemic
J&J’s HIV vaccine failed its first major trial Tuesday, handing another setback to the nearly 40-year effort to build a vaccine against one of the deadliest epidemics in history.
The candidate, which uses the same technology as J&J’s Covid-19 and Ebola shots, was among the last major HIV vaccine constructs in late-stage trials — a holdover from a wave of Big Pharma efforts that have so far gone bust.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 119,800+ biopharma pros reading Endpoints daily — and it's free.